Last Posted: Jun-17-2019 11AM
Last Posted: Jun 14, 2019
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype: What do genetic defects tell us and what are the clinical implications?
Santos Raul D et al. Atherosclerosis 2017 263316-317 - Managing Patients With Homozygous Familial Hypercholesterolemia.
Gidding Samuel S et al. Journal of the American College of Cardiology 2017 70(9) 1171-1172 - A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH).
Cao Ye-Xuan et al. Molecular diagnosis & therapy 2019 Jun - 10-year-old’s cholesterol was over 800. Can CRISPR fix the problem?
T Avril, Philadelphia Inquirer, June 10, 2019 - Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality
M O'Riordan, TCMD Heart Disease, June 5, 2019 - Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia.
Wang Xu et al. Lipids in health and disease 2019 Jun 18(1) 131 - Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
Tada Hayato et al. Current opinion in lipidology 2019 May - Prevalence and Treatment of Familial Hypercholesterolemia in France.
Bérard Emilie et al. The Canadian journal of cardiology 2019 Jun 35(6) 744-752 - Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal Screening.
Francis Gordon A et al. The Canadian journal of cardiology 2019 Jun 35(6) 699-700 - "I Have FH” podcast
A Sheldon, the FH Foundation, June 4, 2019
.jpeg)
No hay comentarios:
Publicar un comentario